“amgen-ventures” Archives

in
Entry Author Date Location
Alector Snags $133M to Activate Immune Cells Against Neurodegeneration 07/25/18 San Francisco
Empatica, Kyruus, Pear & More: Digital Trailblazer Award Finalists 07/23/18 Boston
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
Akili Grabs $55M, Seeking FDA Approval of First Video Game Therapy 05/09/18 Boston
Synthetic Bio Startup Senti Raises $53M to Program Cells to Treat Disease 02/27/18 San Francisco
Akili Interactive Receives $11,900,000 Series B Funding 07/20/16 Boston
Tizona Therapeutics Obtains $43,000,000 Series B Funding 03/08/16 San Francisco
Alector Obtains $29,500,000 Series D Financing 01/07/16 San Francisco
MiRagen Lands $41M for MicroRNA Drugs in Cancer, Fibrosis 11/10/15 Boulder/Denver
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
Ra Pharmaceuticals Receives $58,500,000 Series B Round 07/23/15 Boston
Precision BioSciences Lands $26M for Gene-Editing Technology 05/11/15 Raleigh Durham
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
MiRagen Therapeutics Raises $7M, Extends Deal with France’s Servier 06/26/14 Boulder/Denver
Atara Biotherapeutics Lands $13,500,000 Series B Round 01/10/14 San Diego
Atara Biotherapeutics Receives $38,500,000 Series B Financing 12/18/13 San Diego
Sutro Biopharma Garners $26,000,000 Series D Funding 12/11/13 San Francisco
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Ra Pharmaceuticals Clinches Merck Deal for Up to $200 Million 04/01/13 Boston
Theraclone Secures $14M to Push Antibody Drug Programs 03/25/13 Seattle
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Theraclone Sciences Garners $14,000,000 Series B Financing 03/25/13 Seattle
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug 05/23/12 Boston
Ra Pharmaceuticals Receives $8,600,000 Series A Financing Round 05/16/12 Boston
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
MiRagen Therapeutics Garners $20,000,000 Series B Funding Round 04/24/12 Boulder/Denver
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy 12/22/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Page 1 of 3 next page »